Search by Drug Name or NDC

    NDC 68180-0780-01 ZOLPIDEM TARTRATE 12.5 mg/1 Details

    ZOLPIDEM TARTRATE 12.5 mg/1

    ZOLPIDEM TARTRATE is a ORAL TABLET, EXTENDED RELEASE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Lupin Pharmaceuticals, Inc.. The primary component is ZOLPIDEM TARTRATE.

    Product Information

    NDC 68180-0780
    Product ID 68180-780_0b0d439e-9812-4697-a98b-023eb50fb972
    Associated GPIs 60204080100420
    GCN Sequence Number 059697
    GCN Sequence Number Description zolpidem tartrate TAB MPHASE 12.5 MG ORAL
    HIC3 H2E
    HIC3 Description SEDATIVE-HYPNOTICS,NON-BARBITURATE
    GCN 25457
    HICL Sequence Number 007842
    HICL Sequence Number Description ZOLPIDEM TARTRATE
    Brand/Generic Generic
    Proprietary Name ZOLPIDEM TARTRATE
    Proprietary Name Suffix n/a
    Non-Proprietary Name Zolpidem Tartrate
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form TABLET, EXTENDED RELEASE
    Route ORAL
    Active Ingredient Strength 12.5
    Active Ingredient Units mg/1
    Substance Name ZOLPIDEM TARTRATE
    Labeler Name Lupin Pharmaceuticals, Inc.
    Pharmaceutical Class Central Nervous System Depression [PE], GABA A Agonists [MoA], Pyridines [CS], gamma-Aminobutyric Acid-ergic Agonist [EPC]
    DEA Schedule CIV
    Marketing Category ANDA
    Application Number ANDA078970
    Listing Certified Through 2025-12-31

    Package

    NDC 68180-0780-01 (68180078001)

    NDC Package Code 68180-780-01
    Billing NDC 68180078001
    Package 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (68180-780-01)
    Marketing Start Date 2014-04-11
    NDC Exclude Flag N
    Pricing Information
    Price Per Unit 0.14043
    Pricing Unit EA
    Effective Date 2024-02-21
    NDC Description ZOLPIDEM TART ER 12.5 MG TAB
    Pharmacy Type Indicator C/I
    OTC N
    Explanation Code 1
    Classification for Rate Setting G
    As of Date 2024-02-21
    This pricing file, entitled the NADAC (National Average Drug Acquisition Cost) files, provide state Medicaid agencies with covered outpatient drug prices by averaging survey invoice prices from retail community pharmacies across the United States. These pharmacies include independent retail community pharmacies and chain pharmacies. The prices are updated on a weekly and monthly basis